Patent: 9,943,594
✉ Email this page to a colleague
Summary for Patent: 9,943,594
Title: | Methods for the treatment of rheumatoid arthritis |
Abstract: | The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R). |
Inventor(s): | Jasson; Martine (Paris, FR), Marks; Vanessa (Paris, FR), Huang; Xiaohong (Tarrytown, NY), Radin; Allen (Tarrytown, NY) |
Assignee: | SANOFI BIOTECHNOLOGY (Paris, FR) REGENERON PHARMACEUTICALS, INC. (Tarrytown, NY) |
Application Number: | 13/648,521 |
Patent Claims: | see list of patent claims |
Details for Patent 9,943,594
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2031-10-11 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2031-10-11 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2031-10-11 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2031-10-11 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |